Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-18-031810

President and CEO sold 2,028 shares at $25.09 ($50,880)

  • President and CEO acquired 2,028 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
McCarthy Sean A. President and CEO 2018-07-03 Option exercise +2,028 $1.57 $3,194 84,091 D
McCarthy Sean A. President and CEO 2018-07-03 Sale −2,028 $25.09 $50,880 82,063 D
Derivatives
McCarthy Sean A. President and CEO 2018-07-03 Option exercise · Stock Option (Right to Buy) −2,028 160,146 D
Open-market sales · 2,028 sh · avg $25.09 · $50,880
Loading xslF345X03/doc1.xml…